Novo Nordisk Deal History & Licensing Activity

About Novo Nordisk Licensing & Deal Activity

Novo Nordisk is a large pharma company based in Denmark that has been actively engaged in licensing transactions across the biopharma landscape. With 21 deals over the past three years, Novo Nordisk ranks among the most acquisitive companies tracked by Ambrosia Ventures.

Key therapeutic areas of focus for Novo Nordisk include Metabolic (60 deals and trials), Cardiovascular (9 deals and trials), Codev Deals (3 deals and trials), and Hematology (1 deal and trial). In terms of modality, Novo Nordisk has shown particular interest in peptides, small molecules, small molecules.

Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Novo Nordisk and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Novo Nordisk's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.